Advertisement
News
Subscribe to MDT Magazine News

MAP Pharmaceuticals to Present at Upcoming Investor Conferences

February 23, 2011 3:36 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., Feb. 23, 2011 /- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced that the Company will participate in the following investor conferences in March: Citi's 2011 Global Healthcare Conference Wednesday, March 2, at 3:30 p.m. ET in New YorkRBC Capital Markets'...

TOPICS:

Isis Pharmaceuticals Reports That Its Selective CRP Inhibitor Demonstrated Activity in a Phase 1 Study

February 23, 2011 3:34 am | by Bio-Medicine.Org | Comments

CARLSBAD, Calif., Feb. 23, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announced today the results from a Phase 1 clinical trial in which ISIS-CRPRx produced statistically significant reductions in C-reactive protein (CRP) in the cohort of subjects in the study with elevated CRP....

TOPICS:

Reportlinker Adds Global Medical Ultrasound Equipment Industry

February 23, 2011 3:34 am | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 23, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Medical Ultrasound Equipment Industry http://www.reportlinker.com/p098401/Global-Medical-Ultrasound-Equipment-Industry.html This report analyzes the worldwide...

TOPICS:
Advertisement

Insmed to Host Fourth Quarter and 2010 Year-End Earnings Conference Call

February 23, 2011 3:33 am | by Bio-Medicine.Org | Comments

RICHMOND, Va., Feb. 23, 2011 /- Insmed Incorporated (Nasdaq: INSM ), a biopharmaceutical company, announced today that it will host a conference call on Thursday, March 10th, 2011, at 8:30 AM EST, to discuss its financial results for the fourth quarter and year-end 2010.  Insmed...

TOPICS:

Reportlinker Adds Global Orthopedic Prosthetics Industry

February 23, 2011 2:37 am | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 23, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Orthopedic Prosthetics Industry http://www.reportlinker.com/p090647/Global-Orthopedic-Prosthetics-Industry.html This report analyzes the worldwide markets for...

TOPICS:

Perceptive Informatics Integrates Medical Imaging Tracking with RTSM Technologies for Streamlined Workflow, Improved Data Quality

February 23, 2011 2:37 am | by Bio-Medicine.Org | Comments

BOSTON, Feb. 23, 2011 /- Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL ), today announced the next level of seamless integration between its Medical Imaging Tracking application and ClinPhone®...

TOPICS:

Reportlinker Adds Global Artificial Organs Industry

February 23, 2011 2:36 am | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 23, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Artificial Organs Industry http://www.reportlinker.com/p092544/Global-Artificial-Organs-Industry.html This report analyzes the worldwide markets for Artificial...

TOPICS:

Reportlinker Adds Global Prepackaged Medical Kits and Trays Industry

February 23, 2011 2:35 am | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 23, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Prepackaged Medical Kits and Trays Industry http://www.reportlinker.com/p090645/Global-Prepackaged-Medical-Kits-and-Trays-Industry.html This report analyzes the...

TOPICS:
Advertisement

Reportlinker Adds Global Hematology Instruments and Reagents Industry

February 23, 2011 2:34 am | by Bio-Medicine.Org | Comments

NEW YORK, Feb. 23, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Hematology Instruments and Reagents Industry http://www.reportlinker.com/p092536/Global-Hematology-Instruments-and-Reagents-Industry.html This report analyzes the...

TOPICS:

WellPoint board declares initial 25-cent dividend

February 23, 2011 1:45 am | by The Associated Press | Comments

WellPoint says its board of directors declared an initial dividend of 25 cents, citing its capital position a month after topping Wall Street's earnings expectations and becoming the latest health insurer to make increase its payout.Big health insurers normally offer token dividends like the...

JK Lasers Set To Participate In Medtec UK 2011

February 23, 2011 1:35 am | by RealWire | Comments

Laser Manufacturer to Promote Benefits of Lasers for Medical Device Processing Industrial laser manufacturer, JK Lasers (part of the GSI Group), will be participating in this year's Medtec UK exhibition, part of a series of events designed specifically for the medical device manufacturing...

TOPICS:

NHS Hearing Aids - Free But at What Price?

February 23, 2011 12:34 am | by Bio-Medicine.Org | Comments

PRESTON, England, Feb. 23, 2011 /- In the UK we are fortunate enough to have a free provision of hearing aids by way of the NHS. Over the last few years, the NHS has switched from analogue to digital hearing aids for the majority of patients. These hearing instruments are of a reasonable...

TOPICS:

Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials

February 22, 2011 11:36 pm | by Bio-Medicine.Org | Comments

LONDON, Feb. 23, 2011 /- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") announces the issuance of United States patent 7,893,245, titled "Interfering RNA Molecules," by the United States Patent and Trademark Office (USPTO).  The issued patent, which represents a...

TOPICS:

High Rates of Pathological Complete Response in Patients with Advanced Esophageal Cancer in OPAXIOâ„¢ Phase II Study Reported in American Journal of Clinical Oncology

February 22, 2011 11:35 pm | by Bio-Medicine.Org | Comments

SEATTLE, Feb. 23, 2011 /- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that updated phase II study results of OPAXIO (paclitaxel poliglumex) in patients with advanced esophageal cancer conducted by the Brown University Oncology Group were published in the...

TOPICS:

Quanterix, Novartis sign biomarker deal

February 22, 2011 11:34 pm | by Mass High Tech: The Journal of New England Technology | Comments

Diagnostics company Quanterix Corp. today announced an evaluation agreement with Novartis Diagnostics under which the unit of Novartis AG will look at the potential use of Quanterix's technology on a neuron-specific protein target.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading